Cross-source identity
National Provider Identifier 1366944027 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|---|---|---|
| CMS Open Payments |
| NPI 1366944027 |
| 33 industry-payment records, 2024 |
| Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1366944027 | 29 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
| Fonteum entity graph | entity e0622514… | Canonical resolved node · 2 identifier(s) · 8 edge(s) | Source:Entity graphSnapshot 2026-06-11 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $798 | 33 |
| Manufacturer | Amount | Records |
|---|---|---|
| Boston Scientific Corporation | $468 | 19 |
| Medtronic, Inc. | $113 | 2 |
| Scilex Pharmaceuticals Inc. | $80 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Xtampza Er(Oxycodone Myristate) | 57 | $37,348 |
| Oxycodone-Acetaminophen(Oxycodone Hcl/Acetaminophen) | 419 | $16,847 |
| Ztlido(Lidocaine) | 36 | $15,708 |
| Buprenorphine | 68 | $12,416 |
| Hydrocodone-Acetaminophen(Hydrocodone/Acetaminophen) | 303 | $8,464 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
Ownership & affiliations
One-hop relationships in the resolved entity graph — chain membership, ownership, and operation edges, each backed by a federal source row. Most individual clinicians carry none; edges populate for owners and organizations as the Lane D backfill runs.
| Relationship | Entity | Source |
|---|---|---|
| ← pays | Boston Scientific Corporation (MA) | cms_open_payments |
| ← pays | Vertex Pharmaceuticals Incorporated (MA) | cms_open_payments |
| ← pays | Abbvie Inc. (IL) | cms_open_payments |
| ← pays | Medtronic, Inc. (MN) | cms_open_payments |
| ← pays | Si-Bone, Inc. (CA) | cms_open_payments |
| ← pays | Azurity Pharmaceuticals, Inc. (MA) | cms_open_payments |
| ← pays | Collegium Pharmaceutical, Inc. (MA) | cms_open_payments |
| ← pays | Scilex Pharmaceuticals Inc. (CA) | cms_open_payments |
| 4 |
| Collegium Pharmaceutical, Inc. | $46 | 3 |
| Abbvie Inc. | $35 | 2 |